Article Information
PubMed
History
- Published online December 7, 2009.
Article Versions
- Latest version (December 7, 2009 - 08:20).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009
Author Information
- Irfan A. Dhalla, MD MSc,
- Muhammad M. Mamdani, PharmD MPH,
- Marco L.A. Sivilotti, MD MSc,
- Alex Kopp, BA,
- Omar Qureshi, MD,
- David N. Juurlink, MD PhD
- From the Departments of Medicine (Dhalla, Juurlink) and of Health Policy, Management and Evaluation (Dhalla), University of Toronto, Toronto, Ont.; the Department of Medicine and the Keenan Research Centre of the Li Ka Shing Knowledge Institute (Dhalla, Mamdani), St. Michael’s Hospital, Toronto, Ont.; the Institute for Clinical Evaluative Sciences (Mamdani, Kopp, Juurlink), Toronto, Ont.; the Departments of Emergency Medicine and of Pharmacology and Toxicology (Sivilotti), Queen’s University, Kingston, Ont.; the Department of Family Medicine (Qureshi), State University of New York at Buffalo, Buffalo, USA; Sunnybrook Health Sciences Centre (Juurlink), Toronto, Ont.; and the Faculty of Medicine (Mandani), King Saud University, Riyadh, Saudi Arabia
- Correspondence to:
Dr. Irfan A. Dhalla, Department of Medicine, St. Michael’s Hospital, 30 Bond St., Toronto ON M5B 1W8; dhallai{at}smh.toronto.on.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone
Jump to section
Related Articles
Cited By...
- Influence of opioid prescribing standards on health outcomes among patients with long-term opioid use: a longitudinal cohort study
- Patterns of opioid use (codeine, morphine or meperidine) in the Canadian population over time: analysis of the Longitudinal National Population Health Survey 1994-2011
- Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal
- Exponential growth of the USA overdose epidemic
- Relation between opioid-related harms and socioeconomic inequalities in Ontario: a population-based descriptive study
- Quantity of opioids consumed following an emergency department visit for acute pain: a Canadian prospective cohort study
- Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
- Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
- Refutation : Les nouvelles recommandations sur les opioides nuiront-elles plus quelles aideront les gens?: Non
- Will the new opioid guidelines harm more people than they help?: No
- Rebuttal: Will the new opioid guidelines harm more people than they help?: No
- Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
- Availability of naloxone in Canadian pharmacies:a population-based survey
- Prise en charge des troubles de consommation dopioides en premiere ligne: Abstinence, methadone ou buprenorphine-naloxone?
- Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
- Effective Canadian policy to reduce harms from prescription opioids: learning from past failures
- National opioid crisis
- Trends and sex differences in prescription opioid deaths in British Columbia, Canada
- Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches
- Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths
- Tamper-resistant drugs cannot solve the opioid crisis
- Can naloxone prescription and overdose training for opioid users work in family practice?: Perspectives of family physicians
- Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border
- Neonatal opioid withdrawal and antenatal opioid prescribing
- Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: Evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program
- The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
- Incidence of narcotic abuse during pregnancy in northwestern Ontario: Three-year prospective cohort study
- Trends in high-dose opioid prescribing in Canada
- Questionable content of an industry-supported medical school lecture series: a case study
- Patient therapeutic education: Placing the patient at the centre of the WHO analgesic ladder
- Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis
- Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study
- A Call For Evidence-Based Medical Treatment Of Opioid Dependence In The United States And Canada
- The right drug for the right patient: Caring for our patients while minimizing prescription drug misuse
- Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing
- Opioids for chronic non-cancer pain
- Dependance aux opioides
- Opioid dependence
- Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse
- Don't tamper with oxycodone
- Opioids for osteoarthritis pain: benefits and risks
- Pratiques optimales de prescription: Que peuvent faire les medecins?
- Achieving optimal prescribing: What can physicians do?
- Controler la douleur et reduire l'usage abusif d'opioides: Questions d'ethique
- Controlling pain and reducing misuse of opioids: Ethical considerations
- Prescription opioid use and misuse: Piloting an educational strategy for rural primary care physicians
- Lessons from the past
- Opioids and chronic pain
- Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain
- Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 1: general population
- Usage abusif des opioides d'ordonnance: Quel est le vrai probleme et comment le reglons-nous?
- Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 2: populations particulieres
- Prescription opioid abuse: What is the real problem and how do we fix it?
- Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 2: special populations
- Lignes directrices canadiennes sur l'utilisation securitaire et efficace des opioides pour la douleur chronique non cancereuse: Resume clinique pour les medecins de famille. Partie 1: population en general
- Pharmacists' experiences with dispensing opioids: Provincial survey
- Facing up to the prescription opioid crisis
- Increasing deaths involving oxycodone, Victoria, Australia, 2000-09
- We can't feel their pain, but we can understand their fears.
- Treating patients versus numbers
- Response
- Survey of Ontario primary care physicians' experiences with opioid prescribing
- Chronic noncancer pain: Characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic
- Miconazole Oral Gel Increases Exposure to Oral Oxycodone by Inhibition of CYP2D6 and CYP3A4
- Opioides, douleur et personnalite: Recit d'un medecin remplacant
- Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario
- Opioids, pain, and personality: The story of a substitute physician
- Has the time come to phase out codeine?
- High cost, dubious benefit
- Where are the drugs from?